Refine your interests »
On April 4, 2017, in Novartis AG v. Noven Pharmaceuticals, Inc., the Federal Circuit affirmed the Patent Trial and Appeal Board’s (“PTAB’s”) holding that various claims of U.S. Patents 6,316,023 and 6,335,031 (“the Patents at...more